Search

Your search keyword '"Low-pathogenicity coronavirus"' showing total 2 results
Start Over Descriptor "Low-pathogenicity coronavirus"
2 results on '"Low-pathogenicity coronavirus"'

1. Humoral cross-reactivity towards SARS-CoV-2 in young children with acute respiratory infection with low-pathogenicity coronaviruses

Author

Nitin Dhochak, Tanvi Agrawal, Heena Shaman, Naseem Ahmed Khan, Prawin Kumar, Sushil K. Kabra, Guruprasad R. Medigeshi, and Rakesh Lodha

Subjects
COVID-19, Low-pathogenicity coronavirus, Cross-reactive antibody, Virus microneutralization test, Children, Infectious and parasitic diseases, RC109-216
Abstract

Background: SARS-CoV-2 infection in children frequently leads to only asymptomatic and mild infections. It has been suggested that frequent infections due to low-pathogenicity coronaviruses in children, impart immunity against SARS-CoV-2 in this age group. Methods: From a prospective birth cohort study prior to the pandemic, we identified children with proven low-pathogenicity coronavirus infections. Convalescent sera from these children were tested for antibodies against respective seasonal coronaviruses (OC43, NL63, and 229E) and SARS-CoV-2 by immunofluorescence and virus microneutralization assay respectively. Results: Forty-two children with proven seasonal coronavirus infection were included. Convalescent sera from these samples demonstrated antibodies against the respective seasonal coronaviruses. Of these, 40 serum samples showed no significant neutralization of SARS-CoV-2, while 2 samples showed inconclusive results. Conclusion: These findings suggest that the antibodies generated in low-pathogenicity coronavirus infections offer no protection from SARS-CoV-2 infection in young children.

Published
2022
Full Text
View/download PDF

2. Humoral cross-reactivity towards SARS-CoV-2 in young children with acute respiratory infection with low-pathogenicity coronaviruses

Author

Naseem Ahmed Khan, Nitin Dhochak, Tanvi Agrawal, Prawin Kumar, Rakesh Lodha, Sushil K. Kabra, Guruprasad R. Medigeshi, and Heena Shaman

Subjects
viruses, Short Communication, Infectious and parasitic diseases, RC109-216, medicine.disease_cause, Asymptomatic, Cross-reactivity, Neutralization, Virus, Low-pathogenicity coronavirus, Immunity, Medicine, Microneutralization Assay, skin and connective tissue diseases, Children, biology, business.industry, Cross-reactive antibody, Respiratory infection, virus diseases, COVID-19, biochemical phenomena, metabolism, and nutrition, Virology, respiratory tract diseases, Virus microneutralization test, biology.protein, medicine.symptom, Antibody, business
Abstract

Background: SARS-CoV-2 infection in children frequently leads to only asymptomatic and mild infections. It has been suggested that frequent infections due to low-pathogenicity coronaviruses in children, impart immunity against SARS-CoV-2 in this age group. Methods: From a prospective birth cohort study prior to the pandemic, we identified children with proven low-pathogenicity coronavirus infections. Convalescent sera from these children were tested for antibodies against respective seasonal coronaviruses (OC43, NL63, and 229E) and SARS-CoV-2 by immunofluorescence and virus microneutralization assay respectively. Results: Forty-two children with proven seasonal coronavirus infection were included. Convalescent sera from these samples demonstrated antibodies against the respective seasonal coronaviruses. Of these, 40 serum samples showed no significant neutralization of SARS-CoV-2, while 2 samples showed inconclusive results. Conclusion: These findings suggest that the antibodies generated in low-pathogenicity coronavirus infections offer no protection from SARS-CoV-2 infection in young children.

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results